Nuo Therapeutics, Inc.
AURX
$1.74
$0.2113.73%
OTC PK
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 22.66% | 6.44% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 22.66% | 6.44% | |||
| Cost of Revenue | 40.05% | -14.03% | |||
| Gross Profit | 17.80% | 14.09% | |||
| SG&A Expenses | 18.21% | 10.60% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 20.06% | 7.99% | |||
| Operating Income | -18.42% | -8.97% | |||
| Income Before Tax | -50.21% | 14.10% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -50.21% | 14.10% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -50.21% | 14.10% | |||
| EBIT | -18.42% | -8.97% | |||
| EBITDA | -18.15% | -7.73% | |||
| EPS Basic | -51.43% | 17.32% | |||
| Normalized Basic EPS | -19.05% | -6.33% | |||
| EPS Diluted | -51.43% | 17.32% | |||
| Normalized Diluted EPS | -19.05% | -6.33% | |||
| Average Basic Shares Outstanding | -0.76% | 3.42% | |||
| Average Diluted Shares Outstanding | -0.76% | 3.42% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||